[144] Legend Biotech Corp SEC Filing
Form 144 notice for Legend Biotech Corp (LEGN) reports a proposed sale of 1,000 American Depositary Shares through Fidelity Brokerage Services with an aggregate market value of $33,285 and an approximate sale date of 09/26/2025 on NASDAQ. The shares were acquired on 06/20/2022 as restricted stock vesting from the issuer and were paid as compensation. The filing lists 367,298,315 shares outstanding for the class and discloses a prior sale by Patrick Casey of 1,000 ADS on 06/26/2025 for $33,234. The filer signs the required representation that they are unaware of material nonpublic information.
- Full Rule 144 disclosure provided including broker, acquisition details, and prior three-month sale
- Securities were acquired via restricted stock vesting, clearly stated as compensation
- Insider sale occurred: prior sale of 1,000 ADS on 06/26/2025 is disclosed
Insights
TL;DR: Routine Rule 144 disclosure of an insider sale; filing documents acquisition source and recent sale, satisfying disclosure requirements.
The Form 144 provides the standard items required under Rule 144: identity of broker, number of ADS to be sold, aggregate market value, acquisition date and nature of acquisition, and a prior sale within the three-month lookback period. The filing explicitly states the shares were acquired via restricted stock vesting on 06/20/2022 and identifies the prior sale on 06/26/2025. From a compliance perspective, the document appears complete for a notice of proposed sale and includes the attestation regarding material nonpublic information. No regulatory exceptions or special conditions are disclosed in the filing.
TL;DR: Insiders disclosed a small sale of 1,000 ADS; the item is a routine liquidity event with limited apparent market impact.
The notice shows an insider intends to sell 1,000 American Depositary Shares via Fidelity with an indicated aggregate market value of $33,285. The shares were granted through restricted stock vesting and treated as compensation. The filing also records a previous sale of 1,000 ADS on 06/26/2025 for $33,234. The information supplied is factual and concise; it does not include company financials or forward-looking statements, so its informational impact on the broader investment case is limited based on the filing contents alone.